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Evidence suggests that human semen quality may have been deteriorating in recent years. Most of the evidence is
retrospective, based on analysis of data sets collected for other purposes. Measures of male infertility are needed if we want
to monitor the biological capacity for males to reproduce over time or between different populations. We also need these
measures in analytical epidemiology if we want to identify risk indicators, risk factors, or even causes of an impaired male
fecundity—that is, the male component in the biological ability to reproduce.
The most direct evaluation of fecundity is to measure the time it takes to conceive. Since the time of conception may
be missed in the case of an early abortion, time to get pregnant is often measured as the time it takes to obtain a conception
that survives until a clinically recognized pregnancy or even a pregnancy that ends with a live born child occurs. A
prolonged time required to produce pregnancy may therefore be due to a failure to conceive or a failure to maintain a
pregnancy until clinical recognition. Studies that focus on quantitative changes in fecundity (that does not cause sterility)
should in principle be possible in a pregnancy sample. The most important limitation in fertility studies is that the design
requires equal persistency in trying to become pregnant and rather similar fertility desires and family planning methods in
the groups to be compared. This design is probably achievable in exposure studies that make comparisons with reasonable
comparable groups concerning social conditions and use of contraceptive methods.
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A substantial body of evidence has
accumulated in recent years suggest-
ing that human semen quality may be
deteriorating1-3. Unfortunately, the evi-
dence remains inconclusive, with a
number of publications showing clear
evidence of a fall in sperm counts, and
an equal number showing no evidence
of change. Most of the evidence is ret-
rospective, based on analysis of data
sets collected for other purposes, and
there is little data from outside Europe
and North America. Numerous reports
have recently focused on various as-
pects of adverse trends in male repro-
ductive health, supporting a new con-
cept that poor semen quality, testis
cancer, undescended testis, and hypo-
spadias are symptoms of one underly-
ing entity, the testicular dysgenesis
syndrome, which may be increasingly
common due to adverse environmen-
tal influences4-8.
Measures of male infertility are
needed if we want to monitor the bio-
logical capacity of males to reproduce
over time or between different
populations. We also need these meas-
ures in analytical epidemiology if we
want to identify risk indicators, risk
factors, or even causes of an impaired
male fecundity— that is, the male com-
ponent in the biological ability to re-
produce. The debate concerning a pos-
sible decline in sperm values over
time has clearly demonstrated our lack
of proper instruments and data to be
used in this research1-14.
The measures that have been used
so far span from direct measures of re-
production to indirect surrogate meas-
ures based upon biomarkers15-17. In the
following article, some of the meth-
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odological considerations associated
with these biomarkers will be dis-
cussed.
FERTILITY
Fertility (the actual birth of live
offspring in women of reproductive
age) changes over time and differs
among regions. Possible declining
sperm quality and indications of dete-
riorating male reproductive health
over the last 50 years have generated
wide scientific and public interest.
These trends could result from environ-
mental influences on male fertility and
gamete function. Some of the most
striking data are from the DES story
and the TCDD exposure at the Seveso
disaster; they support the hypothesis
that exogenous chemicals could act as
endocrine disrupters and that these
products could be disseminated in our
environment18. However, other chemi-
cal and physical environmental factors
can also directly disturb male repro-
ductive function, as is the case for ra-
diation exposure19. Correct epidemio-
logical risk assessments for these al-
terations could serve as a basis for ad-
equate prevention programs.
The major determinants for indica-
tions of deteriorating male reproduc-
tive health are probably related to so-
cial factors and access to safe contra-
ceptive methods rather than reduced
biological capacity to reproduce. Un-
fortunately, we do not know how to
isolate the role of fecundity in these
comparisons, and we do not expect the
even rather profound declines in fer-
tility, as reported by several European
populations, reflect change in male fe-
cundity. Measurements of fertility may
on the other hand be a cheap and use-
ful indication of male fecundity when
used within the same population and
within the same period. Studies on tes-
ticular cancer patients reveal a lower
fertility for these men up to the time
of diagnosis than for other men in the
same age groups7,8,20. It is possible that
this reduced fertility reflects differ-
ences in fecundity, although alterna-
tive explanations cannot be ruled out.
Standardized fertility ratios have also
been used in occupational epidemiol-
ogy. Comparing the observed and ex-
pected number of live born children
before, during, and after a given occu-
pational exposure has been used to
demonstrate the effect of
dibromochloropropane (DBCP).21
Fertility as a measure of changes in
fecundity over time and between
countries, however, is not a good in-
dication for male fecundity. In most af-
fluent societies where both males and
females work outside home, the desired
family size tends to be small, and even
couples with severely reduced fertility
will often manage to produce the child
they want. Therefore, factors such as
birth control, sexual desire and ability,
and male and female fecundity all
contribute to the family size. Fecundity
will decline over time as a result of
these changes in population selection.
If male fecundity is closely linked to
hereditable factors, a decline in fecun-
dity may be expected even after a few
generations.
TESTICULAR  DYSGENESIS
SYNDROME
Several reports in the literature
have suggested a possible decline in
human semen quality during the last
50 to 60 years1-14. However, the decline
in sperm counts was suspected to re-
flect changes in the policy of infertil-
ity treatment or a bias in selection of
patients rather than a time-related bio-
logical phenomenon.
A systematic analysis of 61 stud-
ies was undertaken by Carlsen in
1992. It showed a significant decrease
in sperm concentration (from 113 mil-
lion/mL to 66 million/mL) and semen
volume (from 3.4 mL to 2.75 mL) over
the period from 1938 to 199010. These
results have been discussed in the lit-
erature and have stimulated extensive
research. A limitation of the study by
Carlsen comes from the fact that there
is a geographical heterogeneity of se-
men quality. This point has been taken
into account in a new reanalysis of all
available data concerning this problem
published by Swan et al. concerning
101 studies published from 1934 to
199614. Trends over time were esti-
mated separately for each continent,
which allows taking into account the
confounding effect of the area of in-
clusion of the subjects. The average
decline in sperm count was virtually
unchanged from that reported previ-
ously by Carlsen et al. In North
America, the slope was somewhat less
than previously reported. The decline
in Europe was even greater than pre-
viously reported, whereas the few stud-
ies from other continents showed no
trend. These results are consistent with
those of Carlsen et al. and indicate
that, after controlling for abstinence
time, age, percent of men with proven
fertility, and specimen collection
method, there has been a negative
trend in sperm production in Europe
and North America for the period from
1934 to1996. Over this period of time,
the decrease is about 50%.
The largest single study under-
taken on this subject comes from the
analysis of 1351 healthy men volun-
teering for sperm donation in the
sperm bank of Paris.3 After taking into
account all potential covariates, a
yearly decrease of 2.6% in sperm con-
centration, 0.3% in percentage of mo-
tile sperm, and 0.7% in the percentage
of morphologically normal spermato-
zoa were found.
When these observations are
brought together with the increasing
incidence of testicular cancer in all the
countries in which it is measured, and
with the reported increased incidence
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of cryptorchidism and of hypospadias,
the existence of a single syndrome, the
“testicular dysgenesis syndrome”
(TDS), that would associate these 3 el-
ements, seems likely. These anomalies
(decreasing sperm production, testicu-
lar cancer, and male genital tract mal-
formations) are not necessarily associ-
ated in the same individuals, but they
are statistically linked to the popula-
tion level; however, one study showed
that low sperm concentration, poor
spermatozoa motility, and a high pro-
portion of morphologically abnormal
spermatozoa were all associated with
an increased risk of testicular cancer1,2.
It is well documented that rare ge-
netic abnormalities that cause testicu-
lar dysgenesis (45X/46XY and andro-
gen insensitivity) are associated with
a high risk of testicular cancer, often
in combination with undescended tes-
tis and hypospadias22.
TIME  TO  PREGNANCY  (TTP)
The most direct evaluation of fe-
cundity is to measure the time it takes
to conceive. Since the time to concep-
tion may be missed in the case of an
early abortion, TTP is often measured
as the time it takes to produce a con-
ception that survives until clinical rec-
ognized pregnancy or even a preg-
nancy that ends with a live born
child23-27. A prolonged TTP may there-
fore be due to a failure to conceive or
a failure to maintain a pregnancy un-
til a clinical recognition.
Demographers speak about fecun-
dity as the probability of becoming
pregnant within a given menstrual cy-
cle. An expected fecundity is around
0.25 for producing a clinical recog-
nized pregnancy, meaning that 25% of
these couples will become pregnant
the first cycle they try, and 3% will not
succeed within 12 cycles27,28.
The main problems in TTP studies
are related to getting proper measure-
ments from the starting time of the
planned pregnancy, and to getting re-
peated measurements over the TTP pe-
riod. Measurements should perhaps
start 3 months before the starting time
for the male study to allow for the time
of spermatogenesis. The data should at
least include information on the fre-
quency and timing of sexual inter-
course, pregnancy planning, sexual
desire and ability, and male or female
fecundity.
Studies that focus on quantitative
changes in fecundity (that do not
cause sterility) should in principle be
identifiable in a pregnancy sample.
The most important limitation in fer-
tility studies is that the design requires
equal persistency in trying to become
pregnant and rather similar fertility de-
sires and family planning methods in
the groups to be compared. This de-
sign is probably achievable in expo-
sure studies that make comparisons
with reasonably comparable groups
concerning social conditions and use
of contraceptive methods29,30. The al-
ternative is to use surveys that include
non-selected segments of the popula-
tion or population segments that are
only sampled according to their expo-
sure status. These surveys should in-
clude information on important deter-
minants of fecundity and the determi-
nants of being exposed to unprotected
intercourse.
We have limited information on
TTP distribution over time, and the
existing information is of poor qual-
ity31-32. Given these limitations, we
have no indication to support that we
have much longer or shorter TTPs than
what we had 30 to 40 years ago. Limi-
tations in evaluating the TTP in preg-
nancy patients include the exclusion
of fertile couples, differences in com-
pliance rates, differential persistency
in trying, and quality of recall. Limi-
tations in evaluating TTP in the gen-
eral population include low response
rates, that studies may include both
TTP and time of unprotected inter-
course, and that large sample sizes are
required for meaningful results. The
primary methodological limitations in
the TTP studies include the use of
contraceptive methods, infertility
treatment, method of pregnancy test-
ing, and lack of a standardized ques-
tionnaire. These are some of the prob-
lems related to using TTP for measur-
ing a couple’s fecundity and for iso-
lating the male component.
Because of infertility treatment, the
“natural TTP history” is usually not
available for more than 1 to 2 years
depending on how developed the
country is33,34. The standard practice in
data analysis is therefore to stop
counting TTP after 12 months. Perhaps
this practice should be implemented at
9 months for couples who have tried
to become pregnant before. Considera-
tion should also be given to modifi-
cation of life-style habits based on
previous pregnancy experience.35 For
exposures that may have a short term
and reversible effect, this parameter
may cause serious problems that are
often not properly addressed in repro-
ductive epidemiology.
For studies that have fecundity as
the endpoint, semen may be an alter-
native surrogate measure. From an epi-
demiological point of view, there are
2 main related shortcomings; 1 is the
unknown predictive value of most se-
men characteristics for fecundity, and
the other is the difficulty in getting
samples that are not too distorted by
selection bias-related to non-respond-
ers. Many studies based on sperm sam-
ples rely upon populations with re-
sponse rates below 50%, or they are
based on highly selected samples like
those from semen donors or males
seeking infertility treatment. The first
group oversamples those with prob-
lems, and these forces of selection
have most likely changed over time.
Furthermore, studies indicate that
males who volunteer for semen stud-
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ies oversample those with perceived
fertility problems4,5,36,37.
Other biomarkers, including
inhibin B, that only require blood sam-
pling are of interest. Blood may be
available in large population studies
and in biobanks stored over time. Un-
fortunately, we still do not know the
predictive values of inhibin B levels
concerning fecundity.
CONCLUSIONS
The last 10 to 20 years of methodo-
logical research indicate that we must
deal with substantial problems if we
want to monitor fecundity over time. The
present technology is not appropriate for
detecting more subtle changes and will
probably result in misleading interpre-
tations. The best approach is perhaps to
carry out proper population surveys us-
ing standardized questionnaires that
record all time periods of unprotected
sex within the last 5 years and that
chronicle the social, behavioral, and dis-
ease settings needed to interpret the data.
There are good reasons to believe
that important determinants of male fe-
cundity operate early in life, perhaps
even in fetal life. Studies that will per-
mit a life-course approach should be
performed5.
RESUMO
PASQUALOTTO FF e col. - Avaliando
infertilidade masculina: aspectos
epidemiológicos. Rev. Hosp. Clín.
Fac. Med. S. Paulo 58(3):173-178,
2003.
Evidências nos últimos anos suge-
rem que a qualidade seminal humana
talvez esteja deteriorando. Muitas evi-
dências são retrospectivas, baseadas
nas análises de dados coletados com
outros propósitos. Aferições da infer-
tilidade masculina são necessárias se
quisermos monitorar a capacidade bio-
lógica para homens se reproduzirem
com o passar do tempo ou entre popu-
lações diferentes. Nós igualmente ne-
cessitamos avaliar essas aferições em
epidemiologia analítica se quisermos
identificar indicadores de risco, fato-
res de risco ou mesmo a causa para
piora da fecundidade masculina, o
componente masculino da habilidade
biológica para reprodução.
A mais direta avaliação da fecundi-
dade é medir o tempo necessário para
conceber. Uma vez que o tempo da
gravidez pode não ser detectado quan-
do de um aborto precoce, o tempo para
engravidar é geralmente avaliado
como o tempo necessário para obter
gravidez que sobreviva até a detecção
clínica da gravidez ou mesmo a gravi-
dez que resulte no nascimento de uma
criança. Um prolongado tempo para
engravidar talvez decorra de algum
problema inerente ao parto ou falha na
manutenção da gravidez até a detecção
clínica da mesma. Estudos que focali-
zam nas mudanças na fecundabilidade
(sem causar esterilidade) deveriam a
princípio ser identificados numa amos-
tra de mulheres grávidas. A limitação
mais importante é que tal desenho re-
quer não apenas persistência em se tor-
nar grávida, mas também métodos de
planejamento familiar similar em gru-
pos para serem comparados. Isto é pro-
vavelmente alcançado em estudos de
exposição que fazem comparações
com grupos comparáveis com relação
à condição social e método contra-
ceptivo.
DESCRITORES: Infertilidade.
Epidemiologia. Sêmen. Concentra-
ção espermática. Testículo.
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